10-Q/A 1 g07687e10vqza.htm WEBMD HEALTH CORP. WEBMD HEALTH CORP.
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
 
Form 10-Q/A
 
Amendment No. 1 to
 
     
þ
  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the quarterly period ended March 31, 2007
or
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from            to           
 
Commission file number: 0-51547
 
WEBMD HEALTH CORP.
(Exact name of registrant as specified in its charter)
 
     
Delaware
(State of incorporation)
  20-2783228
(I.R.S. Employer Identification No.)
     
111 Eighth Avenue
New York, New York
(Address of principal executive office)
  10011
(Zip code)
 
(212) 624-3700
(Registrant’s telephone number including area code)
 
 
 
 
Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
Yes þ     No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.
 
     Large accelerated filer o Accelerated filer þ Non-accelerated filer o     
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)
 
Yes o     No þ
 
As of May 4, 2007, the Registrant had 8,964,328 shares of Class A Common Stock (including unvested shares of restricted WebMD Class A Common Stock) and 48,100,000 shares of Class B Common Stock outstanding.
 


 

EXPLANATORY NOTE
 
This Amendment No. 1 is being filed to correct the text of Paragraph 4 of Exhibits 31.1 and 31.2 of this Quarterly Report. The manually signed copies of Exhibits 31.1 and 31.2 included all required text; however, the copies of those Exhibits originally filed with the Quarterly Report inadvertently omitted parts of Paragraph 4. No other change is being made by this Amendment No. 1.


2


 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
WebMD Health Corp.
 
  By: 
/s/  Anthony Vuolo
Anthony Vuolo
Executive Vice President and
Chief Financial Officer
 
Date: May 29, 2007


3